Brief: Larimar Therapeutics Inc Selected By FDA To Participate In Start Pilot Program For Nomlabofusp In Friedreich's Ataxia
Larimar Therapeutics Inc LRMR.O :
* LARIMAR THERAPEUTICS INC: SELECTED BY FDA TO PARTICIPATE
IN
START PILOT PROGRAM FOR NOMLABOFUSP IN FRIEDREICH'S ATAXIA
Source text for Eikon: ID:nGNX5LyB6y
Further company coverage: LRMR.O
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update